États-Unis · Plateformes & données · The Motley Fool

Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028

Publié par The Motley Fool · États-Unis il y a 1 h

Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 — Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 · The Motley Fool

Résumé détaillé

Even a small share of the weight loss drug market could lead to a substantial increase in the company's share price.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

South Plains Financial (NASDAQ:SPFI) Director Sells 16,700 Shares of Stock

Collective Mining Ltd. reports Q3 results

Applied Materials Sees Another Record Year in 2027

‘She has a history of financial mismanagement’: My brother cut my sister out of his will. I’m getting everything. Do I tell her?

Dollar bulls stampede to best week Since Sept; Yen teeters near 160

How the Jensen Huang affair changes the outlook for U.S.-China relations